DUBLIN--(BUSINESS WIRE)--The "Wound Debridement Market by Product (Enzymatic, Autolytic (Gels, Ointments), Mechanical (Medical Gauzes), Surgical, Ultrasonic), Wound Type (Diabetic Foot Ulcers, Venous Leg, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global wound debridement market is projected to reach USD 1.16 billion by 2025 from USD 0.82 billion in 2020, at a CAGR of 7.2%.
The growth in this market is attributed to the increasing prevalence of diabetic and pressure ulcers, availability of reimbursement in developed economies, and increasing product approvals. However, the high cost of products is expected to hamper market growth to a certain extent in the coming years.
Enzymatic debridement products accounted for the largest share of the wound debridement market in 2019.
Based on product, the wound debridement market is categorized into enzymatic, autolytic, mechanical, surgical, ultrasonic, and others. The enzymatic debridement products segment is expected to command the largest share of the global wound debridement market in 2020. This is primarily attributed to factors such as their high efficacy in debriding and strong market penetration.
Diabetic foot ulcers register the highest growth in the wound debridement market during the forecast period.
Based on wound type, the market has been segmented into diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers, surgical & traumatic wounds, burns, and other wounds. The DFUs segment is expected to offer growth opportunities for market players during the forecast period, primarily due to the growing patient pool for the condition.
North America will continue to dominate the wound debridement market during the forecast period.
The wound debridement market, by region, has been segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America is the largest market for wound debridement, followed by Europe. Growth in the North American market can be attributed to the increasing prevalence of diabetes, high penetration of enzymatic debridement products, and strong market player presence. However, the Asia Pacific is expected to register the highest CAGR during the forecast period. Growth in this region is driven by the presence of a large patient population and increasing awareness regarding advanced healthcare products.
- Growing Incidence of Diabetes and Associated Wounds
- Rising Incidence of Burn Injuries
- Awareness Programs for Wound Care and Management
- Growth Potential of Emerging Economies
- High Cost of Enzymatic Debridement and Surgical Devices
Focus on Autolytic Debridement & Disposable Products
- Smith & Nephew
- B. Braun Melsungen Ag
- Lohmann & Rauscher
- Mlnlycke Health Care Ab
- Coloplast Corp
- Integra Lifesciences
- Zimmer Biomet
- Medline Industries
- Welcare Industries S.P.A
- Pulsecare Medical
- Arobella Medical
- Advancis Medical
- Rls Global
- Deroyal Industries
- Ez Debride
- Suzhou and Science & Technology Development
For more information about this report visit https://www.researchandmarkets.com/r/i03k27